Nutritional status and its effect on treatment outcome among HIV infected clients receiving HAART in Ethiopia: a cohort study.
OBJECTIVE
The aim of this study was to determine the effects of nutritional status at the start of highly active anti-retroviral therapy on treatment outcomes among HIV/AIDS patients taking HAART at Jimma University Specialized Hospital.


METHODS
We performed a retrospective cohort study involving 340 adults who started highly active anti-retroviral therapy. The patients have been clinically followed for 2 years. Data were extracted from paper based medical charts by trained data collectors from January 30 to February 28, 2014 using data collection format. We entered data into Epi data version 3.1 and then exported to SPSS for windows version 21. Predictors of CD4 change were identified using multivariable linear regression model. Time to an event (death) was estimated by Kaplan-Meier and predictors of mortality were identified by Cox proportional hazard model.


RESULTS
Out of 340 patients, 42 patients died during the follow-up. Twenty-five (59.5 %) deaths were from malnourished group. Age, baseline CD4, sex, baseline HAART and marital status were significant predictors of immunologic recovery at different time points. Malnutrition was associated with lower CD4 recovery and greater hazard of death.


CONCLUSIONS
Malnutrition tends to decrease CD4 recovery and predisposes patient to early death.
Clinical Pharmacy Department, School of Pharmacy, Jimma University, Jimma, Ethiopia.
Sadikalmahdi
S
Hussen
Human Nutrition Department, Jimma University, Jimma, Ethiopia.
Tefera
T
Belachew
Clinical Pharmacy Department, School of Pharmacy, Jimma University, Jimma, Ethiopia.
Nezif
N
Hussien
CD4; Death; Ethiopia; Malnutrition; Survival
BMC Infect Dis. 2008 Apr 22;8:52
18430196
AIDS. 2008 Nov 12;22(17):2331-9
18981772
J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):20-6
12352146
J Infect Dis. 2011 Jul 15;204(2):282-90
21673040
AIDS Res Ther. 2013 Jul 10;10:18
23842109
PLoS One. 2011;6(12):e29625
22216334
Lancet Infect Dis. 2011 Dec;11(12):933-41
21982529
Clin Infect Dis. 2014 May;58(9):1312-21
24457342
HIV Med. 2006 Jul;7(5):323-30
16945078
J Int Assoc Physicians AIDS Care (Chic). 2012 Jan-Feb;11(1):57-65
21951728
N Engl J Med. 1998 Mar 26;338(13):853-60
9516219
PLoS One. 2013 May 14;8(5):e64459
23691224
J Acquir Immune Defic Syndr. 2003 May 1;33(1):66-73
12792357
BMC Infect Dis. 2006 Sep 01;6:136
16948852
Clin Infect Dis. 2001 May 15;32(10):1487-93
11317251
AIDS Res Treat. 2014;2014:867827
25165579
AIDS. 2000 May 5;14(7):863-70
10839595
BMC Infect Dis. 2014 Jun 17;14:331
24938526
AIDS. 2006 Nov 28;20(18):2355-60
17117022
HIV Clin Trials. 2011 Jul-Aug;12(4):222-7
22044858
J Infect Dis. 2001 Apr 15;183(8):1290-4
11262215
J Infect Dis. 2004 Nov 15;190(10):1860-8
15499544
J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):230-6
12394802
HIV Med. 2002 Apr;3(2):75-84
12010353